Oculis Holding AG - Ordinary Shares, CHF 0.01 par value per share (OCS)

Historical Holders from Q1 2023 to Q4 2025

Symbol
OCS on Nasdaq
Type / Class
Equity / Ordinary Shares, CHF 0.01 par value per share
Shares outstanding
57,458,694
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
10,893,907
Holdings value
$191,723,678
% of all portfolios
0%
Number of holders
20
Number of buys
4
Number of sells
14
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Oculis Holding AG - Ordinary Shares, CHF 0.01 par value per share (OCS) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
LSP 7 Cooperative UA 14% $96,360,974 5,752,894 LSP 7 Cooperatieve U.A. 31 Dec 2024
Pivotal bioVenture Partners Fund I, L.P. 4.9% $49,735,384 2,815,476 Nan Fung Group Holdings Limited 30 Sep 2025
BVCF IV, L.P. 5% $36,712,818 2,191,810 BVCF IV, L.P. 27 Nov 2024
As of 30 Sep 2025 Oculis Holding AG - Ordinary Shares, CHF 0.01 par value per share (OCS) has 20 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 10,893,907 shares of 57,458,694 outstanding shares and own 19% of the company stock as of 30 Sep 2025.

Top 25 institutional shareholders of Oculis Holding AG - Ordinary Shares, CHF 0.01 par value per share (OCS) own 19% of the company based on 13F filings as of 30 Sep 2025

Filer Ownership Nb Shares Share Change % Portfolio % Holdings Value
EQT Fund Management S.a r.l. 10% 5,900,294 0% 5.6% $103,727,169
Pivotal bioVenture Partners Investment Advisor LLC 4% 2,300,774 0% 23% $40,447,607
Aberdeen Group plc 2.2% 1,253,119 0% 0.04% $22,217,800
Nan Fung Group Holdings Ltd 0.9% 514,702 0% 15% $9,048,461
SR One Capital Management, LP 0.56% 322,500 0% 0.82% $5,669,550
Alyeska Investment Group, L.P. 0.23% 131,332 0% 0.01% $2,308,817
ACUTA CAPITAL PARTNERS, LLC 0.18% 101,777 -4.6% 1.8% $1,789,240
Compagnie Lombard Odier SCmA 0.17% 97,000 0% 0.02% $1,719,810
Woodline Partners LP 0.15% 83,833 +66% 0.01% $1,473,784
UBS Group AG 0.13% 74,732 -41% 0% $1,313,789
BANK OF AMERICA CORP /DE/ 0.07% 38,535 -4.9% 0% $677,446
GEODE CAPITAL MANAGEMENT, LLC 0.05% 29,436 0% 0% $521,900
NORTHERN TRUST CORP 0.04% 21,804 -6.5% 0% $383,314
STATE STREET CORP 0.02% 12,379 -3.1% 0% $219,480
MORGAN STANLEY 0.01% 6,416 -47% 0% $112,793
Aventura Private Wealth, LLC 0.01% 4,000 0.03% $70,320
China Universal Asset Management Co., Ltd. 0% 1,000 0% $17,580
WOLVERINE ASSET MANAGEMENT LLC 0% 269 0% $4,729
DUPONT CAPITAL MANAGEMENT CORP 0% 4 0% 0% $71
SBI Securities Co., Ltd. 0% 1 -75% 0% $18
MARSHALL WACE, LLP 0% 0 -100% $0
BOSUN ASSET MANAGEMENT, LLC 0% 0 -100% $0
KESTRA PRIVATE WEALTH SERVICES, LLC 0% 0 -100% $0
Bellevue Group AG 0% 0 -100% $0
RAYMOND JAMES FINANCIAL INC 0% 0 -100% $0

Institutional Holders of Oculis Holding AG - Ordinary Shares, CHF 0.01 par value per share (OCS) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q4 4,000 $79,880 $19.97 1
2025 Q3 10,893,907 $191,723,678 -$2,123,823 $17.58 20
2025 Q2 5,105,646 $99,100,716 +$2,469,587 $19.41 23
2025 Q1 4,978,440 $94,739,711 +$28,331,355 $19.03 20
2024 Q4 3,493,543 $59,378,651 +$8,163,517 $17.00 12
2024 Q3 3,013,203 $36,946,526 -$3,838,556 $12.26 10
2024 Q2 3,327,448 $39,763,128 -$771,605 $11.95 11
2024 Q1 3,392,028 $40,873,938 -$7,002,425 $12.05 9
2023 Q4 3,973,142 $44,262,231 +$11,523,877 $11.23 7
2023 Q3 2,916,785 $32,106,736 -$2,324,387 $11.00 9
2023 Q2 3,125,204 $38,536,753 +$147,596 $12.33 10
2023 Q1 3,123,421 $23,191,122 +$23,191,122 $7.43 7